The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation

MLA

Zengli Zhang, et al. “The Novel Estrogenic Receptor GPR30 Alleviates Ischemic Injury by Inhibiting TLR4-Mediated Microglial Inflammation.” Journal of Neuroinflammation, vol. 15, no. 1, July 2018, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12974-018-1246-x.

APA

Zengli Zhang, Pei Qin, Youliang Deng, Zhi Ma, Hang Guo, Haiyun Guo, Yushu Hou, Shiquan Wang, Wangyuan Zou, Yanyuan Sun, Yulong Ma, & Wugang Hou. (2018). The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation. Journal of Neuroinflammation, 15(1), 1–13. https://doi.org/10.1186/s12974-018-1246-x

Chicago

Zengli Zhang, Pei Qin, Youliang Deng, Zhi Ma, Hang Guo, Haiyun Guo, Yushu Hou, et al. 2018. “The Novel Estrogenic Receptor GPR30 Alleviates Ischemic Injury by Inhibiting TLR4-Mediated Microglial Inflammation.” Journal of Neuroinflammation 15 (1): 1–13. doi:10.1186/s12974-018-1246-x.